Literature DB >> 22244782

The association between circulating levels of antimüllerian hormone and follicle number, androgens, and menstrual cycle characteristics in young women.

Susanne Lund Kristensen1, Cecilia Høst Ramlau-Hansen, Claus Yding Andersen, Erik Ernst, Sjurdur Frodi Olsen, Jens Peter Bonde, Anne Vested, Gunnar Toft.   

Abstract

OBJECTIVE: To investigate the association between serum antimüllerian hormone (AMH) and other reproductive parameters in young women.
DESIGN: Cross-sectional study.
SETTING: University hospital. PATIENT(S): Population-based cohort of 256 women: 180 were users and 76 were nonusers of hormonal contraceptives. INTERVENTION(S): None. MAIN OUTCOME MEASURE(S): Antral follicles, androgens, age at menarche, and duration and regularity of menstrual cycle. RESULT(S): AMH levels were lower among users of hormonal contraceptives compared to nonusers. Among nonusers, women with AMH levels in the upper tertile had 55% (95% confidence interval [CI]: 22%-99%) higher levels of total T and 8% (95% CI = 2%-15%) longer menstrual cycles than women with AMH levels in the lower tertile. An increase of 1 ng/mL in AMH was associated with 45% (95% CI = 6%-97%) higher prevalence of irregular menstrual cycles. These associations were not seen among users of hormonal contraceptives. A strong relationship between AMH and follicle number was found in both users and nonusers. CONCLUSION(S): AMH measurements were found to be applicable in evaluation of the reproductive function of young women. However, there may be differences in the way that serum AMH levels can be interpreted depending on whether the woman uses hormonal contraceptives or not.
Copyright © 2012 American Society for Reproductive Medicine. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22244782     DOI: 10.1016/j.fertnstert.2011.12.017

Source DB:  PubMed          Journal:  Fertil Steril        ISSN: 0015-0282            Impact factor:   7.329


  19 in total

1.  Maternal Pre-pregnancy BMI and Reproductive Health of Daughters in Young Adulthood.

Authors:  Saga Elise Mariansdatter; Andreas Ernst; Gunnar Toft; Sjurdur Frodi Olsen; Anne Vested; Susanne Lund Kristensen; Mette Lausten Hansen; Cecilia Høst Ramlau-Hansen
Journal:  Matern Child Health J       Date:  2016-10

2.  Differential Rates of Change in Measures of Ovarian Reserve in Young Cancer Survivors Across the Reproductive Lifespan.

Authors:  Katherine Cameron; Mary D Sammel; Maureen Prewitt; Clarisa Gracia
Journal:  J Clin Endocrinol Metab       Date:  2019-05-01       Impact factor: 5.958

3.  Antimüllerian hormone levels are lower in BRCA2 mutation carriers.

Authors:  Lauren Johnson; Mary D Sammel; Susan Domchek; Allison Schanne; Maureen Prewitt; Clarisa Gracia
Journal:  Fertil Steril       Date:  2017-05       Impact factor: 7.329

4.  Ovarian reserve in an Egyptian cohort with end-stage kidney disease on hemodialysis and after successful kidney transplantation: a prospective study.

Authors:  Ahmed Fayed; Ahmed Soliman; Mervat Naguib; Mahmoud Soliman; M Salaheldin
Journal:  Int Urol Nephrol       Date:  2019-02-08       Impact factor: 2.370

5.  Increased androgen, anti-Müllerian hormone, and sporadic anovulation in healthy, eumenorrheic women: a mild PCOS-like phenotype?

Authors:  Lindsey A Sjaarda; Sunni L Mumford; Kerri Kissell; Karen C Schliep; Ahmad O Hammoud; Neil J Perkins; Jennifer Weck; Jean Wactawski-Wende; Enrique F Schisterman
Journal:  J Clin Endocrinol Metab       Date:  2014-02-28       Impact factor: 5.958

6.  Intrauterine, Infant, and Childhood Factors and Ovarian Reserve in Young African American Women.

Authors:  Kristen Upson; Helen B Chin; Erica E Marsh; Donna D Baird
Journal:  J Womens Health (Larchmt)       Date:  2019-01-14       Impact factor: 2.681

7.  Antimüllerian hormone and antral follicle count are lower in female cancer survivors and healthy women taking hormonal contraception.

Authors:  Lauren N C Johnson; Mary D Sammel; Katherine E Dillon; Lara Lechtenberg; Allison Schanne; Clarisa R Gracia
Journal:  Fertil Steril       Date:  2014-06-14       Impact factor: 7.329

8.  Starting and resulting testosterone levels after androgen supplementation determine at all ages in vitro fertilization (IVF) pregnancy rates in women with diminished ovarian reserve (DOR).

Authors:  Norbert Gleicher; Ann Kim; Andrea Weghofer; Aya Shohat-Tal; Emanuela Lazzaroni; Ho-Joon Lee; David H Barad
Journal:  J Assist Reprod Genet       Date:  2012-12-05       Impact factor: 3.412

9.  Pretreatment antimüllerian hormone levels determine rate of posttherapy ovarian reserve recovery: acute changes in ovarian reserve during and after chemotherapy.

Authors:  Katherine E Dillon; Mary D Sammel; Maureen Prewitt; Jill P Ginsberg; Dana Walker; Jennifer E Mersereau; Yasmin Gosiengfiao; Clarisa R Gracia
Journal:  Fertil Steril       Date:  2012-10-18       Impact factor: 7.329

Review 10.  Involvement of androgens in ovarian health and disease.

Authors:  M Lebbe; T K Woodruff
Journal:  Mol Hum Reprod       Date:  2013-09-10       Impact factor: 4.025

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.